Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 17780/1057.
Pregabalin Zentiva hard capsules
Pregabalin Zentiva 25 mg hard capsules
Pregabalin Zentiva 50 mg hard capsules
Pregabalin Zentiva 75 mg hard capsules
Pregabalin Zentiva 100 mg hard capsules
Pregabalin Zentiva 150 mg hard capsules
Pregabalin Zentiva 200 mg hard capsules
Pregabalin Zentiva 225 mg hard capsules
Pregabalin Zentiva 300 mg hard capsules
pregabalin
1. What Pregabalin Zentiva is and what it is used for
2. What you need to know before you take Pregabalin Zentiva
3. How to take Pregabalin Zentiva
4. Possible side effects
5. How to store Pregabalin Zentiva
6. Contents of the pack and other information
Pregabalin Zentiva belongs to a group of medicines used to treat epilepsy, neuropathic pain and generalised anxiety disorder (GAD) in adults.
Pregabalin Zentiva is used to treat long lasting pain caused by damage to the nerves. A variety of diseases can cause peripheral neuropathic pain, such as diabetes or shingles. Pain sensations may be described as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, tingling, numbness, pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbance, fatigue (tiredness), and can have an impact on physical and social functioning and overall quality of life.
Pregabalin Zentiva is used to treat a certain form of epilepsy (partial seizures with or without secondary generalisation) in adults. Your doctor will prescribe Pregabalin Zentiva for you to help treat your epilepsy when your current treatment is not controlling your condition. You should take Pregabalin Zentiva in addition to your current treatment. Pregabalin Zentiva is not intended to be used alone, but should always be used in combination with other anti-epileptic treatment.
Pregabalin Zentiva is used to treat generalised anxiety disorder (GAD). The symptoms of GAD are prolonged excessive anxiety and worry that are difficult to control. GAD can also cause restlessness or feeling keyed up or on edge, being easily fatigued (tired), having difficulty concentrating or mind going blank, feeling irritable, having muscle tension or sleep disturbance. This is different to the stresses and strains of everyday life.
Talk to your doctor or pharmacist before taking Pregabalin Zentiva.
Some people may become dependent on Pregabalin Zentiva (a need to keep taking the medicine). They may have withdrawal effects when they stop using Pregabalin Zentiva (see section 3, “How to take Pregabalin Zentiva” and “If you stop taking Pregabalin Zentiva”) If you have concerns that you may become dependent on Pregabalin Zentiva, it is important that you consult your doctor.
If you notice any of the following signs whilst taking Pregabalin Zentiva, it could be a sign that you have become dependent:
If you notice any of these, speak to your doctor to discuss the best treatment pathway for you, including when it is appropriate to stop and how to do this safely.
The safety and efficacy in children and adolescents (under 18 years of age) has not been established and therefore, pregabalin should not be used in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Pregabalin Zentiva and certain other medicines may influence each other (interaction). When taken with certain other medicines, which have sedative effects (including opioids), pregabalin may potentiate these effects, and could lead to respiratory failure, coma and death. The degree of dizziness, sleepiness and decreased concentration may be increased if pregabalin is taken together with medicines containing:
Pregabalin Zentiva may be taken with oral contraceptives.
Pregabalin Zentiva hard capsules may be taken with or without food. It is advised not to drink alcohol while taking Pregabalin Zentiva.
Pregabalin may produce dizziness, sleepiness and decreased concentration. You should not drive, operate complex machinery or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Do not take more medicine than prescribed.
Your doctor will determine what dose is appropriate for you.
Pregabalin Zentiva is for oral use only.
Take the number of hard capsules as instructed by your doctor.
The dose, which has been adjusted for you and your condition, will generally be between 150 mg and 600 mg each day.
Your doctor will tell you to take Pregabalin Zentiva either twice or three times a day. For twice a day take Pregabalin Zentiva once in the morning and once in the evening, at about the same time each day. For three times a day take Pregabalin Zentiva once in the morning, once in the afternoon and once in the evening, at about the same time each day. If you have the impression that the effect of Pregabalin Zentiva is too strong or too weak, talk to your doctor or pharmacist.
If you are an elderly patient (over 65 years of age), you should take Pregabalin Zentiva normally except if you have problems with your kidneys.
Your doctor may prescribe a different dosing schedule and/or dose if you have problems with your kidneys.
Swallow the capsule whole with water.
Continue taking Pregabalin Zentiva until your doctor tells you to stop.
Call your doctor or go to the nearest hospital emergency unit immediately. Take your box of Pregabalin Zentiva hard capsules with you. You may feel sleepy, confused, agitated, or restless as a result of taking more Pregabalin Zentiva than you should. Fits and unconsciousness (coma) have also been reported.
It is important to take your Pregabalin Zentiva hard capsules regularly at the same time each day. If you forget to take a dose, take it as soon as you remember unless it is time for your next dose. In that case, just carry on with the next dose as normal. Do not take a double dose to make up for a forgotten dose.
Do not suddenly stop taking Pregabalin Zentiva.
If you want to stop taking Pregabalin Zentiva, discuss this with your doctor first. They will tell you how to do this. If your treatment is stopped it should be done gradually over a minimum of 1 week.
After stopping a short or long term treatment with Pregabalin Zentiva, you need to know that you may experience certain side effects, so called withdrawal effects. These effects include, trouble sleeping, headache, nausea, feeling anxious, diarrhoea, flu-like symptoms, convulsions, nervousness, depression, thoughts of harming or killing yourself, pain, sweating, and dizziness. These effects may occur more commonly or severely if you have been taking Pregabalin Zentiva for a longer period of time. If you experience withdrawal effects, you should contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience swollen face or tongue or if your skin turns red and starts to blister or peel, you should seek immediate medical advice.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from the available data
After stopping a short or long-term treatment with Pregabalin Zentiva, you need to know that you may experience certain side effects, so-called withdrawal effects (see “If you stop taking Pregabalin Zentiva”).
Certain side effects may be more common, such as sleepiness, because patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity, that have similar side effects to pregabalin and the severity of these effects may be increased when taken together.
The following adverse reaction has been reported in the post-marketing experience: Trouble breathing, shallow breaths.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after “EXP”. The expiry date refers to the last day of that month.
Do not store above 25 °C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
25 mg capsules Light grey cap and light grey body; approx. 15.9 mm in length, hard gelatin capsule with imprinting “25”, containing almost white powder.
50 mg capsules Light grey cap and light grey body; approx. 14.3 mm in length, hard gelatin capsule with imprinting “50”, containing almost white powder.
75 mg capsules Red cap and light grey body; approx. 14.3 mm in length, hard gelatin capsule with imprinting “75”, containing almost white powder.
100 mg capsules Red cap and red body; approx. 15.9 mm in length, hard gelatin capsule with imprinting “100”, containing almost white powder.
150 mg capsules Light grey cap and light grey body; approx. 18.0 mm in length, hard gelatin capsule with imprinting “150”, containing almost white powder.
200 mg capsules Flesh opaque cap and Flesh opaque body; approx. 19.4 mm in length, hard gelatin capsule with imprinting “200”, containing almost white powder.
225 mg capsules Flesh opaque cap and light grey body; approx. 19.4 mm in length, hard gelatin capsule with imprinting “225”, containing almost white powder.
300 mg capsules Red cap and light grey body; approx. 21.7 mm in length, hard gelatin capsule with imprinting “300”, containing almost white powder.
Pregabalin Zentiva 25 mg hard capsules are packed into alu/alu (OPA/alu/PVC/alu) or PVC/PVDC/alu blisters as primary packaging.
Pregabalin Zentiva 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 25 mg and 50 mg is available in packs of 14, 21, 56, 84, 98 and 100 hard capsules.
Pregabalin Zentiva 75 mg, 150 mg, 225 mg and 300 mg is available in packs of 14, 56, 98 and 100 hard capsules.
Pregabalin Zentiva 100 mg, 200 mg is available in packs of 21, 84, 98 and 100 hard capsules.
Not all pack sizes may be marketed.
or
This leaflet was last revised in February 2024
943073